Trial intelligence / Profile preview

Parecoxib for postoperative pain in Chinese subjects

NCT00143169Phase 3Completed

Sponsor
Pfizer
Start
Sep 2004
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in postoperative pain comparing Parecoxib with Placebo (2 arms). Primary endpoint: Morphine-sparing effect. Started Sep 2004; status: completed.

02

Drugs

parecoxib
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00143169.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00143169.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call